Activation of EMT enables cancer cells to lose their epithelial property but acquire a mesenchymal, migratory phenotype through downregulating epithelial markers including ZO-1 and E-cadherin and upregulating mesenchymal markers such as N-cadherin and Vimentin (24). This evidence concerns the gene CDH1 and cancer.